Routine

Coeliac Disease

GI / Hepatology · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

An immune-mediated enteropathy triggered by dietary gluten in genetically susceptible (HLA- DQ2/DQ8) individuals. Presentation is protean; diagnosis rests on serology and duodenal histology while on gluten, and treatment is a lifelong gluten-free diet.

Red flags

  • Refer for diagnostic endoscopy and dietitian in all suspected cases
  • Re-refer non- responsive or refractory disease, suspected lymphoma (new weight loss, pain, B symptoms), and for complex deficiency or pregnancy management

Assessment

Investigations

  • IgA anti-tissue transglutaminase (anti-tTG) with total IgA (use IgG-based test if IgA deficient) WHILE eating gluten
  • Confirm with OGD and duodenal biopsies (Marsh grading)
  • HLA-DQ2/DQ8 has high negative predictive value
  • Check FBC, ferritin, folate, B12, calcium, vitamin D, bone profile

Management

  • Lifelong strict gluten-free diet with specialist dietitian input; this is the cornerstone
  • Correct deficiencies (iron, folate, B12, vitamin D/calcium)
  • Pneumococcal vaccination (functional hyposplenism)
  • DEXA for osteoporosis risk
  • Dermatitis herpetiformis may need dapsone

Disposition

Refer for diagnostic endoscopy and dietitian in all suspected cases.

Complications & pitfalls

  • Osteoporosis/fractures, iron-deficiency anaemia, functional hyposplenism, infertility and adverse pregnancy outcomes
  • Refractory coeliac disease, enteropathy-associated T-cell lymphoma and small-bowel adenocarcinoma in poorly controlled disease

Exam pearls

  • Do not advise a gluten-free diet before serology and biopsy: stopping gluten normalises antibodies and histology within weeks and makes the diagnosis impossible to confirm. Test on, not off, gluten.
  • Monitoring & follow-up: Annual review: symptoms, dietary adherence, BMI, and falling anti-tTG as a marker of compliance. Recheck haematinics and bone health. DEXA at diagnosis/menopause. Investigate non-responders for ongoing gluten exposure or refractory disease.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.